Polymorphisms in several hormone pathway genes, including CYP19A1 and COMT, have been associated with endogenous hormone levels [13-16]; however, studies investigating the association of genetic variation in hormone metabolism genes and breast cancer risk have generated mixed results [14,17-29]. This evidence concerns the gene COMT and breast cancer.